EBITDA Margin ratio Analysis of INmune Bio Inc - Deep Dive
Latest FY EBITDA Margin
Period Ending - Dec-23
Very Poor EBITDA Margin
-12246.88
Period Ending - Dec-22
Excellent EBITDA Margin
7299.20
Growth
-267.78 %
Trailing Twelve Months EBITDA Margin
Period Ending - Dec-23
Very Poor EBITDA Margin
-10679.33
Most recent Quarter EBITDA Margin
Period Ending - Mar-24
Very Poor EBITDA Margin
-78692.86
EBITDA Margin Analysis of INmune Bio Inc
Ebitda Margin Ratio of INmune Bio Inc with value of -10679.33 means that its operating expenses are Higher in relation to total revenue in trailing twelve months. |
Ebitda Margin Ratio of INmune Bio Inc with value of -78692.86 means that its operating expenses are Higher in relation to total revenue in latest Quarter ending on Mar-24. |
EBITDA Margin Ratio of INMB drastically fell by -267.78 % this year. |
EBITDA Margin Ratio with value of 16762.43 was highest in Year Dec-21 in last Five Years. |
EBITDA Margin Ratio with value of -110838.76 was lowest in Year Dec-20 in last Five Years. |
Latest EBITDA Margin Ratio with value of -12246.88 is Greater than Average EBITDA Margin of -19806.78 in last five years. |
Ebitda Margin of INmune Bio Inc is negative because of negative EBITDA in last Financial Year , last Quarter and also in last twelve Months |
Other EBITDA Margin Related Info of INMB that may interest you.
INmune Bio Inc Overview
Code | Price | Previous Price | Price Change | Sector |
---|---|---|---|---|
INMB | 10.85 | 11.17 | 2.86 % | Biotechnology |
Defination of EBITDA Margin
EBITDA Margin is the profitability ratio that measures a company's earnings before interest, taxes, depreciation, and amortization as a percentage of revenue. EBITDA is the abbreviation for Earnings before Interest, Taxes, Depreciation, and Amortization. more ..EBITDA Margin Related Ratios
NetProfitMargin | ReturnOnEquity |
Tsr Profitability Index
Poor Profitability Stock |
FY - Historical EBITDA Margin of INmune Bio Inc
Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
---|---|---|---|---|---|---|---|
EBITDA Margin | -12246.88 | 7299.20 | 16762.43 | -110838.76 | -9.88 | 0 | 0 |
Change | -267.78 % | -56.46 % | 115.12 % | -1121349.67 % |
FY Chart of EBITDA Margin of INmune Bio Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)